ASHLEY GLASER: Open Payments
NPI 1437711470 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 30 payments from 8 companies in 2025. Trend: 2023 $648 · 2024 $1,034 · 2025 $764
Food & beverage: $665Education: $99
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 7 | $166 |
| Astellas Pharma US Inc | 4 | $145 |
| Abbott Laboratories | 1 | $123 |
| Exeltis, USA Inc. | 6 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Sumitomo Pharma America, Inc. | 4 | $66 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $58 |
| MILLICENT US INC | 2 | $32 |
Products named: ZURZUVAE, CARDIOMEMS, SLYND, MYFEMBREE, Veozah, INTRAROSA, Kyleena, Mirena.
Industry payments across TN — which companies pay providers there.
